Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
2 and Supplementary Table 2
TRANSCEND-T2D-1 Results by Dose (40 Weeks) The 16.8% weight loss in this population is substantially below TRIUMPH-1's 28.3% a pattern consistent across the GLP-1 drug class, where type 2 diabetes reduces the magnitude of weight loss compared to non-diabetic obesity populations
Patients using these medications have not been studied in SYMLIN clinical trials [see Warnings and Precautions (5.6)]
Medications Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Compounded Monthly Cost $75-$499/mo Speed to Start Fast Trustpilot 4.10 / 5 (3700+ reviews) Est
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
